Company Overview
NeoGenomics, Inc. specializes in cancer genetics testing and information services, providing one of the most comprehensive oncology-focused testing menus in the world for physicians to help them diagnose and treat cancer. The Company's Pharma
Services Division serves pharmaceutical clients in clinical trials and drug development.
Headquartered in Fort Myers, FL, NeoGenomics operates CAP accredited and CLIA certified laboratories in Fort Myers and Tampa, Florida; Aliso Viejo, Carlsbad and San Diego, California; Research Triangle Park, North Carolina; Houston, Texas; Atlanta, Georgia; Nashville, Tennessee; and Phoenix, Arizona; and CAP accredited laboratories in Cambridge, and United Kingdom. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States and Europe.
Recent news
NeoGenomics Reports Fourth Quarter and Full Year 2024 Results
NeoGenomics to Report Fourth Quarter and Full Year 2024 Financial Results on February 18, 2025
NeoGenomics Provides 2025 Financial Guidance and Updates Long-Range Financial Plan
Stock Overview
02/21/2025 09:00 PM EST